Suppr超能文献

发现分子胶降解剂的途径。

Routes to molecular glue degrader discovery.

作者信息

Liu Yanfen, Bai Jieyun, Li Dong, Cang Yong

机构信息

School of Life Science and Technology, ShanghaiTech University, 201210 Shanghai, China.

School of Life Science and Technology, ShanghaiTech University, 201210 Shanghai, China.

出版信息

Trends Biochem Sci. 2025 Feb;50(2):134-142. doi: 10.1016/j.tibs.2024.12.006. Epub 2025 Jan 2.

Abstract

Molecular glue degraders (MGDs) represent a unique class of targeted protein degradation (TPD) modalities. By facilitating protein-protein interactions between E3 ubiquitin ligases and neo-substrates, MGDs offer a novel approach to target previously undruggable or insufficiently drugged disease-causing proteins. Here, we present an overview of recently reported MGDs, highlighting their diverse mechanisms, and we discuss mechanism-based strategies to discover new MGDs and neo-substrates. These strategies include repurposing existing E3 ubiquitin ligase-targeting ligands, screening for novel binders to proteins of interest, and leveraging functional genomics and quantitative proteomics to probe the MGD mechanism of action. Despite their historically serendipitous discovery, MGDs are on their way to being rationally designed to deplete undesired proteins by purposely altering the evolutionarily conserved ligase:substrate interactions.

摘要

分子胶降解剂(MGDs)是一类独特的靶向蛋白质降解(TPD)模式。通过促进E3泛素连接酶与新底物之间的蛋白质-蛋白质相互作用,MGDs提供了一种新方法来靶向先前难以成药或药物作用不足的致病蛋白。在这里,我们概述了最近报道的MGDs,突出了它们多样的机制,并讨论了基于机制的发现新MGDs和新底物的策略。这些策略包括重新利用现有的靶向E3泛素连接酶的配体、筛选针对感兴趣蛋白质的新型结合剂,以及利用功能基因组学和定量蛋白质组学来探究MGDs的作用机制。尽管MGDs的发现历来具有偶然性,但它们正朝着通过有意改变进化保守的连接酶:底物相互作用来合理设计以消耗不需要的蛋白质的方向发展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验